These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32380992)

  • 1. Correction to: Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.
    Yoshikawa T; Otsuka M; Chiba H; Ikeda K; Mori Y; Umeda Y; Nishikiori H; Kuronuma K; Takahashi H
    BMC Pulm Med; 2020 May; 20(1):131. PubMed ID: 32380992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction to: Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy.
    Malekmohammad M; Folkerts G; Kashani BS; Naghan PA; Dastenae ZH; Khoundabi B; Garssen J; Mortaz E; Adcock IM
    BMC Pulm Med; 2019 Nov; 19(1):197. PubMed ID: 31690288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.
    Greene KE; King TE; Kuroki Y; Bucher-Bartelson B; Hunninghake GW; Newman LS; Nagae H; Mason RJ
    Eur Respir J; 2002 Mar; 19(3):439-46. PubMed ID: 11936520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to: Complexation with C
    Grebinyk A; Prylutska S; Grebinyk S; Prylutskyy Y; Ritter U; Matyshevska O; Dandekar T; Frohme M
    Nanoscale Res Lett; 2019 Mar; 14(1):91. PubMed ID: 30868449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant protein-A in lung lavage fluid obtained from patients with idiopathic pulmonary fibrosis.
    Behera D; Kaur S; Sathyanarayana G; Majumdar S
    J Assoc Physicians India; 2002 Nov; 50():1409-12. PubMed ID: 12583473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue and Bronchoalveolar Lavage Biomarkers in Idiopathic Pulmonary Fibrosis Patients on Pirfenidone.
    Ronan N; Bennett DM; Khan KA; McCarthy Y; Dahly D; Bourke L; Chelliah A; Cavazza A; O'Regan K; Moloney F; Plant BJ; Henry MT
    Lung; 2018 Oct; 196(5):543-552. PubMed ID: 30066212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia.
    Yamakawa H; Hagiwara E; Ikeda S; Iwasawa T; Otoshi R; Tabata E; Okuda R; Sekine A; Baba T; Iso S; Okudela K; Takemura T; Ogura T
    Respir Investig; 2019 Sep; 57(5):422-429. PubMed ID: 31003951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone.
    Ikeda K; Shiratori M; Chiba H; Nishikiori H; Yokoo K; Saito A; Hasegawa Y; Kuronuma K; Otsuka M; Yamada G; Takahashi H
    Respir Med; 2017 Oct; 131():184-191. PubMed ID: 28947028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to: Mapping a Plasmodium transmission spatial suitability index in Solomon Islands: a malaria monitoring and control tool.
    Jeanne I; Chambers LE; Kazazic A; Russell TL; Bobogare A; Bugoro H; Otto F; Fafale G; Amjadali A
    Malar J; 2018 Nov; 17(1):431. PubMed ID: 30453973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction to: An Arabidopsis introgression zone studied at high spatio-temporal resolution: interglacial and multiple genetic contact exemplified using whole nuclear and plastid genomes.
    Hohmann N; Koch MA
    BMC Genomics; 2018 Apr; 19(1):245. PubMed ID: 29642870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction to: The polymorphism and geographical distribution of knockdown resistance of adult Anopheles sinensis populations in eastern China.
    Tan WL; Li CX; Lv RC; Dong YD; Guo XX; Xing D; Zhou MH; Xu Y; Chu HL; Wang G; Zhu CQ; Sun J; Zhao TY
    Malar J; 2019 May; 18(1):183. PubMed ID: 31138226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction to: First molecular description, phylogeny and genetic variation of Taenia hydatigena from Nigerian sheep and goats based on three mitochondrial genes.
    Ohiolei JA; Luka J; Zhu GQ; Yan HB; Li L; Magaji AA; Alvi MA; Wu YT; Li JQ; Fu BQ; Jia WZ
    Parasit Vectors; 2019 Nov; 12(1):547. PubMed ID: 31752988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications.
    Nair GB; Matela A; Kurbanov D; Raghu G
    Expert Rev Respir Med; 2016 Jun; 10(6):699-711. PubMed ID: 27094006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction to: Tissue and cell-specific transcriptomes in cotton reveal the subtleties of gene regulation underlying the diversity of plant secondary cell walls.
    MacMillan CP; Birke H; Chuah A; Brill E; Tsuji Y; Ralph J; Dennis ES; Llewellyn D; Pettolino FA
    BMC Genomics; 2018 Apr; 19(1):261. PubMed ID: 29665776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction to: An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men.
    Armstrong AJS; Shaffer M; Nusbacher NM; Griesmer C; Fiorillo S; Schneider JM; Neff CP; Li SX; Fontenot AP; Campbell T; Palmer BE; Lozupone CA
    Microbiome; 2020 Apr; 8(1):50. PubMed ID: 32252810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction to: USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health.
    Labonté R; Crosbie E; Gleeson D; McNamara C
    Global Health; 2019 Jul; 15(1):44. PubMed ID: 31262313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction to: Carbon Dots @ Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy.
    Wu F; Yue L; Su H; Wang K; Yang L; Zhu X
    Nanoscale Res Lett; 2019 Jan; 14(1):16. PubMed ID: 30627874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.
    White ES; Xia M; Murray S; Dyal R; Flaherty CM; Flaherty KR; Moore BB; Cheng L; Doyle TJ; Villalba J; Dellaripa PF; Rosas IO; Kurtis JD; Martinez FJ
    Am J Respir Crit Care Med; 2016 Nov; 194(10):1242-1251. PubMed ID: 27149370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis.
    Barlo NP; van Moorsel CH; Ruven HJ; Zanen P; van den Bosch JM; Grutters JC
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):155-61. PubMed ID: 20560296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.